Washington Leads Life Sciences Job Growth
Washington State continues to stand out as a top destination for life sciences professionals. According to a new economic impact report from Life Science Washington, the state recorded a remarkable 50% increase in life sciences employment between 2014 and 2024. Notably, the state posted the same 50% growth rate in the previous decade, from 2013 to 2023, as well.
In 2024, Washington’s life sciences workforce grew from 47,868 to 48,765 employees. That represents a 1.9% year-on-year increase. Furthermore, this growth stands in sharp contrast to the national trend. Across the United States, life sciences employment actually declined by 0.3% in 2024.
Life Science Washington CEO Marc Cummings admitted the numbers surprised him. He expected a more significant slowdown. Instead, Washington’s midmarket sector proved highly resilient. Midcap companies continued expanding, driving the state’s employment numbers upward.
How Washington Compares to Other States
California Posts Solid Growth
California also recorded positive results in 2024. According to California Life Sciences data, the state’s life sciences employment grew by 2.6%. Major hubs in the San Francisco Bay Area and San Diego contributed significantly to that figure. However, analysts warn that the pace of growth in California could slow in the coming years.
Massachusetts Sees Growth Flatten
Massachusetts told a different story. According to a Massachusetts Biotechnology Education Foundation report, life sciences employment there grew by just 0.03% in 2024. After more than a decade of consistent increases, growth in that state has essentially stalled. Nevertheless, projections suggest a potential rebound, with an estimated 11.6% growth expected by 2029.
Washington Holds a Competitive Edge
By comparison, Washington’s 1.9% growth rate in 2024 places it comfortably ahead of several major life sciences markets. Moreover, the state’s trajectory reflects structural changes in how companies operate and invest there.
Key Sectors Driving Employment in Washington
Washington currently hosts 1,100 life sciences organizations spread across 147 cities. These companies span a wide range of focus areas. Biotechnology, research, and testing firms lead the way, with 404 companies operating in this space. Medical devices and equipment companies come in second, with 254 organizations. Digital health and health IT firms rank third, with 240 companies active in the state.
Big Companies Staying Put
One major factor behind Washington’s decade-long growth is the shift in corporate strategy. Large companies no longer automatically absorb smaller acquisitions and move operations elsewhere. For example, Pfizer acquired Seagen, a leading antibody-drug conjugate company based in Bothell, Washington, for $43 billion in 2023. Significantly, Pfizer chose to keep Seagen’s operations in Bothell rather than relocate them. This decision signals that Washington has become a place where companies want to build and grow.
Hiring Outlook for 2026
Companies Are Cautious But Active
Not every company is aggressively hiring right now. Cummings explained that many life sciences employers are conserving cash and waiting to see how financing conditions evolve. Stock indices for biotech have turned upward. Late-stage deals are progressing. However, earlier-stage companies are still waiting for funding to flow through.
Active Hiring Spots in Washington
Despite the cautious environment, hiring continues across the state. Contract manufacturing organization Jubilant HollisterStier, based in Spokane, brings on hundreds of new employees annually. Biotech firm SystImmune, headquartered in Redmond, is currently in a strong hiring phase. Both companies list open positions on their websites. Therefore, job seekers should check these organizations directly.
Layoffs and Challenges Ahead
Industry Cuts Hit Washington, But Less Severely
Layoffs remain a challenge across the life sciences sector in 2026. Washington has not escaped these cuts entirely. SonomaBio let go of an unspecified number of employees in Seattle. Astellas Pharma designated 50 employees for cuts as part of the upcoming closure of the Seattle office of Universal Cells, its wholly owned subsidiary. Some of those employees may take internal transfers within Astellas. Additionally, Seattle-based Faraday Pharmaceuticals announced it is winding down operations entirely.
However, Cummings noted that Washington has seen fewer workforce reductions than markets like Boston or San Diego. Consequently, the state’s life sciences job market remains comparatively stable.
Long-Term Growth Potential Stays Intact
Will Washington achieve another 50% employment jump between 2024 and 2034? Cummings cannot predict exact numbers. Nevertheless, he confirmed that the underlying growth trend remains firmly in place.
Why Professionals Choose Washington
Beyond employment numbers, Washington offers a compelling quality of life. Cummings highlighted the state’s outdoor lifestyle, vibrant arts scene, and strong food culture as major draws. Professionals who move to Washington often find an environment that balances hard work with meaningful recreation. As Cummings put it, the culture supports working hard while also enjoying excellent weekends.
For life sciences professionals seeking opportunity and lifestyle, Washington continues to offer both in abundance.
